Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Immunogenicity of Combined sIPV and DTaP in Infants
NCT04053010Phase 4Unknown
- Sponsor
- China National Biotec Group
- Start
- Aug 2019
- Primary completion
- Dec 2019
- Modality
- Recombinant Proteins and Enzymes, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of Sabin strain inactivated poliovirus vaccine, diphtheria + tetanus + acellular pertussis vaccine in poliomyelitis, diphtheria, Tetanus, pertussis, sponsored by China National Biotec Group. Status: unknown.
02
Drugs
Sabin strain inactivated poliovirus vaccinediphtheria + tetanus + acellular pertussis vaccine
03
Conditions
poliomyelitisdiphtheriaTetanuspertussis
Beyond the preview
Go deeper on NCT04053010.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04053010.